130 related articles for article (PubMed ID: 35724303)
1. Assessing the Utility of the Montreal Cognitive Assessment in Screening for Cognitive Impairment in Patients With Systemic Lupus Erythematosus.
Tayer-Shifman OE; Yuen K; Green R; Kakvan M; Katz P; Bingham KS; Diaz-Martinez JP; Ruttan L; Wither JE; Tartaglia MC; Su J; Bonilla D; Choi MY; Appenzeller S; Barraclough M; Beaton DE; Touma Z
Arthritis Care Res (Hoboken); 2023 Mar; 75(3):569-577. PubMed ID: 35724303
[TBL] [Abstract][Full Text] [Related]
2. Validity Evidence for the Use of Automated Neuropsychologic Assessment Metrics As a Screening Tool for Cognitive Impairment in Systemic Lupus Erythematosus.
Tayer-Shifman OE; Green R; Beaton DE; Ruttan L; Wither JE; Tartaglia MC; Kakvan M; Lombardi S; Anderson N; Su J; Bonilla D; Zandy M; Choi MY; Fritzler MJ; Touma Z
Arthritis Care Res (Hoboken); 2020 Dec; 72(12):1809-1819. PubMed ID: 31628718
[TBL] [Abstract][Full Text] [Related]
3. Validation of the automated neuropsychological assessment metrics for assessing cognitive impairment in systemic lupus erythematosus.
Yuen K; Beaton D; Bingham K; Katz P; Su J; Diaz Martinez JP; Tartaglia MC; Ruttan L; Wither JE; Kakvan M; Anderson N; Bonilla D; Choi MY; Fritzler MJ; Green R; Touma Z
Lupus; 2022 Jan; 31(1):45-54. PubMed ID: 34957878
[TBL] [Abstract][Full Text] [Related]
4. Screening for cognitive dysfunction in systemic lupus erythematosus: the Montreal Cognitive Assessment Questionnaire and the Informant Questionnaire on Cognitive Decline in the Elderly.
Chalhoub NE; Luggen ME
Lupus; 2019 Jan; 28(1):51-58. PubMed ID: 30482092
[TBL] [Abstract][Full Text] [Related]
5. Screening for cognitive impairment in systemic lupus erythematosus: Application of the Montreal Cognitive Assessment (MoCA) in a Greek patient sample.
Papastefanakis E; Dimitraki G; Ktistaki G; Fanouriakis A; Karamaouna P; Bardos A; Kallitsakis I; Adamichou C; Gergianaki I; Repa A; Bertsias G; Sidiropoulos P; Karademas E; Simos P
Lupus; 2021 Dec; 30(14):2237-2247. PubMed ID: 34861804
[TBL] [Abstract][Full Text] [Related]
6. Cognitive dysfunction in SLE: development of a screening tool.
Adhikari T; Piatti A; Luggen M
Lupus; 2011 Oct; 20(11):1142-6. PubMed ID: 21676920
[TBL] [Abstract][Full Text] [Related]
7. Montreal cognitive assessment as a screening instrument for cognitive impairment in systemic lupus erythematosus patients without overt neuropsychiatric manifestations.
Lim XR; Chew POK; Lim GH; Low YL; Lim JWP; Ong HN; Law WG; Tan JWL; Thong BY; Chia FL; Lian TY; Chan GYL; Chan MT; Koh ET; Kong KO; Howe HS
Lupus; 2022 Dec; 31(14):1759-1769. PubMed ID: 36218127
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in SLE.
Raghunath S; Glikmann-Johnston Y; Morand E; Stout JC; Hoi A
Lupus Sci Med; 2021 Dec; 8(1):. PubMed ID: 34911821
[TBL] [Abstract][Full Text] [Related]
9. Metrics and definitions used in the assessment of cognitive impairment in systemic lupus erythematosus: A systematic review.
Yuen K; Green R; Bingham K; Ruttan L; Lee-Kim V; Tartaglia MC; Anderson M; Zandy M; Choi MY; Fritzler MJ; Wither JE; Beaton DE; Katz P; Touma Z
Semin Arthritis Rheum; 2021 Aug; 51(4):819-830. PubMed ID: 34157577
[TBL] [Abstract][Full Text] [Related]
10. Performance of Screening Tests for Cognitive Impairment in Systemic Lupus Erythematosus.
Nantes SG; Su J; Dhaliwal A; Colosimo K; Touma Z
J Rheumatol; 2017 Nov; 44(11):1583-1589. PubMed ID: 28864643
[TBL] [Abstract][Full Text] [Related]
11. The Montreal Cognitive Assessment Test: A Useful Tool in Screening of Cognitive Impairment in Patients With Systemic Lupus Erythematosus.
Paez-Venegas N; Jordan-Estrada B; Chavarria-Avila E; Perez-Vazquez F; Gómez-Bañuelos E; Medina-Dávalos R; Ontiveros-González JÁ; Diaz-Rubio GI; Navarro-Hernandez RE; Vázquez-Del Mercado M
J Clin Rheumatol; 2019 Dec; 25(8):325-328. PubMed ID: 31764492
[TBL] [Abstract][Full Text] [Related]
12. Use of computerized assessment to predict neuropsychological functioning and emotional distress in patients with systemic lupus erythematosus.
Roebuck-Spencer TM; Yarboro C; Nowak M; Takada K; Jacobs G; Lapteva L; Weickert T; Volpe B; Diamond B; Illei G; Bleiberg J
Arthritis Rheum; 2006 Jun; 55(3):434-41. PubMed ID: 16739211
[TBL] [Abstract][Full Text] [Related]
13. Cognitive dysfunction in Sjögren's syndrome using the Montreal Cognitive Assessment Questionnaire and the Automated Neuropsychological Assessment Metrics: A cross-sectional study.
Riega-Torres JCL; Treviño-Castro MA; Hernandez-Galarza IJ; Garza-Martinez MJ; Vera-Pineda R; Cardenas-de la Garza JA; Rodriguez-de la Garza P; Skinner-Taylor CM; Galarza-Delgado DA
Int J Rheum Dis; 2020 Aug; 23(8):1019-1023. PubMed ID: 32608054
[TBL] [Abstract][Full Text] [Related]
14. Cognitive Performance in Patients with Systemic Lupus Erythematosus Using the Ped-ANAM.
de Amorim JC; Sepresse SR; Vivaldo JF; Julio PR; Kishimoto ST; Marini R; Fernandes PT; Costallat LTL; Appenzeller S
Cells; 2022 Dec; 11(24):. PubMed ID: 36552818
[TBL] [Abstract][Full Text] [Related]
15. The validation of the Beijing version of the Montreal Cognitive Assessment in Chinese patients undergoing hemodialysis.
Tian R; Guo Y; Ye P; Zhang C; Luo Y
PLoS One; 2020; 15(1):e0227073. PubMed ID: 31917792
[TBL] [Abstract][Full Text] [Related]
16. Initial validation of the Pediatric Automated Neuropsychological Assessment Metrics for childhood-onset systemic lupus erythematosus.
Brunner HI; Ruth NM; German A; Nelson S; Passo MH; Roebuck-Spencer T; Ying J; Ris D
Arthritis Rheum; 2007 Oct; 57(7):1174-82. PubMed ID: 17907235
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of cognitive impairment using the Montreal Cognitive Assessment questionnaire among patients with systemic lupus erythematosus: a cross-sectional study at two tertiary centres in Malaysia.
Kanapathy A; Nik Jaafar NR; Shaharir SS; Chan LF; Rozita M; Ch'ng SS
Lupus; 2019 Jun; 28(7):854-861. PubMed ID: 31159651
[TBL] [Abstract][Full Text] [Related]
18. Serum S100A8/A9 and MMP-9 levels are elevated in systemic lupus erythematosus patients with cognitive impairment.
Muñoz-Grajales C; Barraclough ML; Diaz-Martinez JP; Su J; Bingham K; Kakvan M; Kretzmann RP; Tartaglia MC; Ruttan L; Choi MY; Appenzeller S; Marzouk S; Bonilla D; Katz P; Beaton D; Green R; Gladman DD; Wither J; Touma Z
Front Immunol; 2023; 14():1326751. PubMed ID: 38332909
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of the Montreal Cognitive Assessment (MoCA) for cognitive screening in old age psychiatry: Determining cutoff scores in clinical practice. Avoiding spectrum bias caused by healthy controls.
Dautzenberg G; Lijmer J; Beekman A
Int J Geriatr Psychiatry; 2020 Mar; 35(3):261-269. PubMed ID: 31650623
[TBL] [Abstract][Full Text] [Related]
20. Criterion and convergent validity of the Montreal cognitive assessment with screening and standardized neuropsychological testing.
Lam B; Middleton LE; Masellis M; Stuss DT; Harry RD; Kiss A; Black SE
J Am Geriatr Soc; 2013 Dec; 61(12):2181-2185. PubMed ID: 24320735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
